Secondary hematopoietic malignancies in survivors of childhood cancer: An analysis of 111 cases from the surveillance, epidemiology, and end result-9 registry

Cancer

Volumn 116, Issue 18, 2010, Pages 4385-4394

  Rihani, Rawad ^a   Bazzeh, Faiha ^a   Faqih, Nesreen ^a   Sultan, Iyad ^a  

^a KING HUSSEIN CANCER CENTER   (Jordan)

Author keywords

Acute lymphoblastic leukemia; Acute myeloid leukemia; Childhood cancer; Hematopoietic cancers; Lymphoma; Secondary cancers; Surveillance, Epidemiology, and End Results (SEER); Survivors

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; INFANT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEWBORN; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; HEMATOLOGIC NEOPLASMS; INCIDENCE; MORTALITY; NEOPLASMS; NEOPLASMS, SECOND PRIMARY; PRESCHOOL CHILD; SURVIVOR; TIME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; NEOPLASMS; NEOPLASMS, SECOND PRIMARY; SEER PROGRAM; SURVIVORS; TIME FACTORS;

EID: 77957329916     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25313     Document Type: Article

References (42)

1. Inskip PD, Curtis RE. New malignancies following childhood cancer in the United States, 1973-2002. Int J Cancer. 2007;121:2233-2240.
2. Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in 5-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 2001;93:618-629. (Pubitemid 32409629)
3. Bhatia S, Krailo MD, Chen Z, et al. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: a report from the Children's Oncology Group. Blood. 2007;109:46-51.
4. Navid F, Billups C, Liu T, Krasin MJ, Rodriguez-Galindo C. Second cancers in patients with the Ewing sarcoma family of tumours. Eur J Cancer. 2008;44:983-991.
5. Pui CH, Ribeiro RC, Hancock ML, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med. 1991;325:1682-1687.
6. Godley LA, Larson RA. Therapy-related myeloid leukemia. Semin Oncol. 2008;35:418-429.
7. Le Deley MC, Leblanc T, Shamsaldin A, et al. Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol. 2003;21:1074-1081.
8. Kushner BH, Heller G, Cheung NK, et al. High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors. J Clin Oncol. 1998;16:3016-3020.
9. Heyn R, Khan F, Ensign LG, et al. Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report. Med Pediatr Oncol. 1994;23:99-106.
10. Smith MA, Rubinstein L, Anderson JR, et al. Secondary leukemia or myelodysplatic syndrome after treatment with epipodophyllotoxins. J Clin Oncol. 1999;17:569-577.
11. Travis LB. The epidemiology of second primary cancers. Cancer Epidemiol Biomarkers Prev. 2006;15:2020-2026.
12. Felix CA, Walker AH, Lange BJ, et al. Association of CYP3A4 genotype with treatment-related leukemia. Proc Natl Acad Sci U S A. 1998;95:13176-13181.
13. Allan JM, Wild CP, Rollinson S, et al. Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc Natl Acad Sci U S A. 2001;98:11592-11597.
14. Bassal M, Mertens AC, Taylor L, et al. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006;24:476-483.
15. Caglar K, Varan A, Akyuz C, et al. Second neoplasms in pediatric patients treated for cancer: a center's 30-year experience. J Pediatr Hematol Oncol. 2006;28:374-378.
16. Barnard DR, Lange B, Alonzo TA, et al. Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation. Blood. 2002;100:427-434.
17. Hijiya N, Ness KK, Ribeiro RC, Hudson MM. Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues. Cancer. 2009;115:23-35.
18. Metayer C, Lynch CF, Clarke EA, et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol. 2000;18:2435-2443.
19. Jenkinson HC, Hawkins MM, Stiller CA, Winter DL, Marsden HB, Stevens MC. Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain. Br J Cancer. 2004;91:1905-1910.
20. Kaldor JM, Day NE, Clarke EA, et al. Leukemia following Hodgkin's disease. N Engl J Med. 1990;322:7-13.
21. Hijiya N, Hudson MM, Lensing S, et al. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA. 2007;297:1207-1215.
22. Schoch C, Kern W, Schnittger S, Hiddemann W, Haferlach T. Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML. Leukemia. 2004;18:120-125.
23. Pulsoni A, Pagano L. Treatment of secondary acute myeloid leukemia. J Clin Oncol. 2005;23:926-927.
24. Zuna J, Cave H, Eckert C, et al. Childhood secondary ALL after ALL treatment. Leukemia. 2007;21:1431-1435.
25. Hunger SP, Sklar J, Link MP. Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: report of 3 cases and review of the literature. J Clin Oncol. 1992;10:156-163.
26. Shivakumar R, Tan W, Wilding GE, Wang ES, Wetzler M. Biologic features and treatment outcome of secondary acute lymphoblastic leukemia - a review of 101 cases. Ann Oncol. 2008;19:1634-1638.
27. Bhatia S, Sklar C. Second cancers in survivors of childhood cancer. Nat Rev Cancer. 2002;2:124-132.
28. Imamura J, Miyoshi I, Koeffler HP. p53 in hematologic malignancies. Blood. 1994;84:2412-2421.
29. Liberzon E, Avigad S, Stark B, et al. Germ-line ATM gene alterations are associated with susceptibility to sporadic Tcell acute lymphoblastic leukemia in children. Genes Chromosomes Cancer. 2004;39:161-166.
30. Tartaglia M, Gelb BD. Noonan syndrome and related disorders: genetics and pathogenesis. Annu Rev Genomics Hum Genet. 2005;6:45-68.
31. Ragusa R, Russo S, Villari L, Schiliro G. Hodgkin's disease as a second malignant neoplasm in childhood: report of a case and review of the literature. Pediatr Hematol Oncol. 2001;18:407-414.
32. Zarate-Osorno A, Medeiros LJ, Kingma DW, Longo DL, Jaffe ES. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of 9 cases. Am J Surg Pathol. 1993;17:123-132.
33. Amini RM, Enblad G, Sundstrom C, Glimelius B. Patients suffering from both Hodgkin's disease and non-Hodgkin's lymphoma: a clinico-pathological and immuno-histochemical population-based study of 32 patients. Int J Cancer. 1997;71:510-516.
34. Travis LB, Gonzalez CL, Hankey BF, Jaffe ES. Hodgkin's disease following non-Hodgkin's lymphoma. Cancer. 1992;69:2337-2342.
35. Kim HS, Roh HO, Kang SH, et al. Hodgkin's disease in a child with acute lymphoblastic leukemia. Yonsei Med J. 1991;32:270-274.
36. Bennett MH, MacLennan KA, Vaughan Hudson G, Vaughan Hudson B. Non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: a 20-year experience. British National Lymphoma Investigation. Ann Oncol. 1991;2(suppl 2):83-92.
37. Van Leeuwen FE, Somers R, Taal BG, et al. Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease. J Clin Oncol. 1989;7:1046-1058.
38. Henry-Amar M. Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease. Ann Oncol. 1992;3(suppl 4):117-128.
39. Green DM, Hyland A, Barcos MP, et al. Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence. J Clin Oncol. 2000;18:1492-1499.
40. Rueffer U, Josting A, Franklin J, et al. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis. J Clin Oncol. 2001;19:2026-2032.
41. Bhatia S, Robison LL, Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med. 1996;334:745-751.
42. Ma X, Does M, Raza A, Mayne ST. Myelodysplastic syndromes: incidence and survival in the United States. Cancer. 2007;109:1536-1542. (Pubitemid 46595689)